Singapore markets close in 2 hours 57 minutes
  • Straits Times Index

    3,222.95
    +18.38 (+0.57%)
     
  • Nikkei

    29,050.94
    -55.07 (-0.19%)
     
  • Hang Seng

    25,619.75
    -418.52 (-1.61%)
     
  • FTSE 100

    7,277.62
    +54.80 (+0.76%)
     
  • BTC-USD

    61,028.70
    -1,363.39 (-2.19%)
     
  • CMC Crypto 200

    1,488.16
    -16.99 (-1.13%)
     
  • S&P 500

    4,574.79
    +8.31 (+0.18%)
     
  • Dow

    35,756.88
    +15.73 (+0.04%)
     
  • Nasdaq

    15,235.71
    +9.01 (+0.06%)
     
  • Gold

    1,787.20
    -6.20 (-0.35%)
     
  • Crude Oil

    83.86
    -0.79 (-0.93%)
     
  • 10-Yr Bond

    1.6190
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,585.24
    +1.04 (+0.07%)
     
  • Jakarta Composite Index

    6,605.44
    -51.50 (-0.77%)
     
  • PSE Index

    7,230.15
    -21.95 (-0.30%)
     

Thermo Fisher Scientific to manufacture Nucleic Acid Isolation Kits in India

·2-min read
Thermo Fisher Scientific to manufacture Nucleic Acid Isolation Kits in India
Thermo Fisher Scientific to manufacture Nucleic Acid Isolation Kits in India

Mumbai (Maharashtra) [India], September 28 (ANI/PNN): Thermo Fisher Scientific, the world leader in serving science, today announced that it will manufacture its Applied Biosystems MagMAX Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kits in India for the Indian market.

The kit is used to isolate and purify viral RNA and DNA from human saliva, nasopharyngeal and oropharyngeal swabs, providing a faster, more precise and easier-to-use solution for customers.

The MagMax Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit will be manufactured in Thermo Fisher's state-of-the-art manufacturing facility in Bengaluru. The site is currently used to produce CoviPath RT-PCR COVID-19 testing kits for customers in India.

The isolation kit is designed for use by qualified and trained clinical laboratory personnel. It has been approved for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and the Drug Control General of India (DCGI).

"Thermo Fisher Scientific has played a pivotal role in the global response against COVID-19, and we have made significant investments to support our customers in India," said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific. "While the situation is gradually improving, the world still needs more advanced solutions that improve testing quality and sustain bulk testing with less processing time, and the MagMAX Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit will support this effort," added Amit.

The isolation kit enables highly scalable, accessible, faster and more consistent viral RNA and DNA extraction and can process up to 96 samples in 30 minutes. It comes with pre-filled, automation-ready media plates that can be used with Kingfisher Flex instruments with special automation-ready compatibility with the Thermo Scientific Kingfisher Flex Purification System.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately USD 35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them.

Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting